Yuling Liu
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery 12
- Advanced Drug Delivery Systems 10
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 21
- Toxicology top 5%
- Molecular Medicine top 5%
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 17
- Ginseng Biological Effects and Applications 6
- Bioactive natural compounds 6
-
- Nanoplatforms for cancer theranostics 12
-
- Pharmacological Effects of Natural Compounds 7
- Journals
- International Journal of Nanomedicine (9 papers)Molecules (6 papers)Journal of Ethnopharmacology (4 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Yuling Liu
105 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Pharmaceutical Science 403
- Biomaterials 479
- Toxicology 66
- Molecular Medicine 90
- Molecular Biology 1.0k
Countries citing papers authored by Yuling Liu
This map shows the geographic impact of Yuling Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuling Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuling Liu more than expected).
Fields of papers citing papers by Yuling Liu
This network shows the impact of papers produced by Yuling Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuling Liu. The network helps show where Yuling Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuling Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 14 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 13 | |
| 10 | 2023 | 13 | |
| 11 | 2022 | 5 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 10 | |
| 14 | 2020 | 25 | |
| 15 | 2019 | 142 | |
| 16 | Determination of saponins of Gynostemma pentaphyllum extract by high performance liquid chromatography. | 2018 | 1 |
| 17 | 2017 | 46 | |
| 18 | 2016 | 45 | |
| 19 | 2015 | 3 | |
| 20 | Determination of mulberry twig alkaloids by RP-HPLC with pre-column derivatization | 2008 | 1 |
About Yuling Liu
Yuling Liu is a scholar working on Pharmaceutical Science, Biomaterials and Pharmacology, having authored 112 papers that have together received 2.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (21 papers), RNA Interference and Gene Delivery (17 papers), Nanoplatforms for cancer theranostics (12 papers), Advancements in Transdermal Drug Delivery (12 papers), Advanced Drug Delivery Systems (10 papers), Pharmacological Effects of Natural Compounds (7 papers), Ginseng Biological Effects and Applications (6 papers) and Bioactive natural compounds (6 papers). The work is most often cited by research in Pharmaceutical Science (403 citations), Biomaterials (479 citations) and Toxicology (66 citations). Yuling Liu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Longfei Lin, Lei Yan, Xuejun Xia, Hui Li, Hui Li, Jian Ni, Yanfang Yang, Cuiping Zhou, Hongliang Wang and Hongjun Yang. Their work appears in journals such as International Journal of Nanomedicine, Molecules, Journal of Ethnopharmacology, Journal of Pharmaceutical and Biomedical Analysis and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.